APOE and Cognitive impairment: Compared to people with the APOE 3/3 gene, carriers of the APOE 3/4 gene show significantly more cognitive impairments related to working memory, visuospatial memory, and executive function 2.5 and 5 h after administration of lorazepam (Stonnington et al., 2017).